Back to Explorer

21CFR522.1083

§ 522.1083 Gonadotropin releasing factor analog-diphtheria toxoid conjugate.

Regulation Text

(a) Specifications. Each milliliter (mL) of solution contains 0.2 milligrams (mg) gonadotropin releasing factor analog-diphtheria toxoid conjugate. (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter . (c) Conditions of use in swine — (1) Amount. Each intact male pig or gilt should receive two 2-mL (0.4 mg) doses by subcutaneous injection. Administer the first dose no earlier than 9 weeks of age. Administer the second dose at least 4 weeks after the first dose. (2) Indications for use — (i) Intact male pigs intended for slaughter: For the temporary immunological castration (suppression of testicular function) and reduction of boar taint. (ii) Gilts intended for slaughter: For the temporary suppression of estrus. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For reduction of boar taint, intact male pigs should be slaughtered no earlier than 3 weeks and no later than 10 weeks after the second dose.

Authority

21 U.S.C. 360b.

View in Graph Explorer
21CFR522.1083 — § 522.1083 Gonadotropin releasing factor analog-diphtheria toxoid conjugate. | CFR Explorer | BioRegHub